US Stock MarketDetailed Quotes

FDMT 4D Molecular Therapeutics

Watchlist
  • 15.010
  • -0.240-1.57%
Close Aug 30 16:00 ET
  • 15.010
  • 0.0000.00%
Post 16:45 ET
780.06MMarket Cap-6700P/E (TTM)

4D Molecular Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-97.91%5K
-90.60%28K
562.29%20.72M
-101.52%-19K
3,940.80%20.2M
47.53%239K
-75.55%298K
-82.65%3.13M
1,255.43%1.25M
-63.40%500K
Operating revenue
-97.91%5K
-90.60%28K
562.29%20.72M
-101.52%-19K
3,940.80%20.2M
47.53%239K
-75.55%298K
-82.65%3.13M
1,255.43%1.25M
-63.40%500K
Cost of revenue
Gross profit
Operating expense
31.15%42.46M
25.52%38.16M
18.05%133.59M
22.24%36.63M
26.61%34.18M
13.25%32.38M
10.12%30.4M
26.62%113.16M
20.56%29.97M
12.35%27M
Selling and administrative expenses
20.59%10.6M
28.80%10.29M
10.90%36.49M
25.25%10.61M
13.12%9.11M
7.65%8.79M
-2.89%7.99M
17.48%32.91M
15.54%8.47M
-1.61%8.06M
-General and administrative expense
20.59%10.6M
28.80%10.29M
10.90%36.49M
25.25%10.61M
13.12%9.11M
7.65%8.79M
-2.89%7.99M
17.48%32.91M
15.54%8.47M
-1.61%8.06M
Research and development costs
35.09%31.86M
24.35%27.87M
20.99%97.1M
21.06%26.03M
32.34%25.07M
15.48%23.58M
15.64%22.41M
30.79%80.25M
22.66%21.5M
19.57%18.94M
Operating profit
-32.11%-42.46M
-26.67%-38.14M
-2.58%-112.87M
-27.62%-36.65M
47.26%-13.97M
-13.05%-32.14M
-14.07%-30.11M
-54.25%-110.03M
-15.97%-28.72M
-16.92%-26.5M
Net non-operating interest income expense
200.48%7.55M
298.13%5.75M
374.58%12.21M
227.35%4.38M
387.55%3.88M
638.82%2.51M
1,343.00%1.44M
1,778.10%2.57M
528.85%1.34M
82.76%795K
Non-operating interest income
200.48%7.55M
298.13%5.75M
374.58%12.21M
227.35%4.38M
387.55%3.88M
638.82%2.51M
1,343.00%1.44M
1,778.10%2.57M
528.85%1.34M
82.76%795K
Other net income (expense)
-662.50%-45K
47.37%-10K
-417.14%-181K
-466.67%-11K
-1,855.56%-158K
8K
58.70%-19K
71.07%-35K
142.86%3K
169.23%9K
Other non- operating income (expenses)
-662.50%-45K
47.37%-10K
-417.14%-181K
-466.67%-11K
-1,855.56%-158K
--8K
58.70%-19K
71.07%-35K
142.86%3K
169.23%9K
Income before tax
-18.02%-34.95M
-12.97%-32.4M
6.19%-100.84M
-17.91%-32.28M
60.08%-10.26M
-5.45%-29.62M
-8.90%-28.68M
-50.73%-107.49M
-9.15%-27.38M
-15.52%-25.69M
Income tax
Net income
-18.02%-34.95M
-12.97%-32.4M
6.19%-100.84M
-17.91%-32.28M
60.08%-10.26M
-5.45%-29.62M
-8.90%-28.68M
-50.73%-107.49M
-9.15%-27.38M
-15.52%-25.69M
Net income continuous Operations
-18.02%-34.95M
-12.97%-32.4M
6.19%-100.84M
-17.91%-32.28M
60.08%-10.26M
-5.45%-29.62M
-8.90%-28.68M
-50.73%-107.49M
-9.15%-27.38M
-15.52%-25.69M
Minority interest income
Net income attributable to the parent company
-18.02%-34.95M
-12.97%-32.4M
6.19%-100.84M
-17.91%-32.28M
60.08%-10.26M
-5.45%-29.62M
-8.90%-28.68M
-50.73%-107.49M
-9.15%-27.38M
-15.52%-25.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-18.02%-34.95M
-12.97%-32.4M
6.19%-100.84M
-17.91%-32.28M
60.08%-10.26M
-5.45%-29.62M
-8.90%-28.68M
-50.73%-107.49M
-9.15%-27.38M
-15.52%-25.69M
Basic earnings per share
18.18%-0.63
25.00%-0.66
22.29%-2.58
8.33%-0.77
69.62%-0.24
11.49%-0.77
-7.32%-0.88
-29.18%-3.32
1.18%-0.84
3.66%-0.79
Diluted earnings per share
18.18%-0.63
25.00%-0.66
22.29%-2.58
8.33%-0.77
69.62%-0.24
11.49%-0.77
-7.32%-0.88
-29.18%-3.32
1.18%-0.84
3.66%-0.79
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -97.91%5K-90.60%28K562.29%20.72M-101.52%-19K3,940.80%20.2M47.53%239K-75.55%298K-82.65%3.13M1,255.43%1.25M-63.40%500K
Operating revenue -97.91%5K-90.60%28K562.29%20.72M-101.52%-19K3,940.80%20.2M47.53%239K-75.55%298K-82.65%3.13M1,255.43%1.25M-63.40%500K
Cost of revenue
Gross profit
Operating expense 31.15%42.46M25.52%38.16M18.05%133.59M22.24%36.63M26.61%34.18M13.25%32.38M10.12%30.4M26.62%113.16M20.56%29.97M12.35%27M
Selling and administrative expenses 20.59%10.6M28.80%10.29M10.90%36.49M25.25%10.61M13.12%9.11M7.65%8.79M-2.89%7.99M17.48%32.91M15.54%8.47M-1.61%8.06M
-General and administrative expense 20.59%10.6M28.80%10.29M10.90%36.49M25.25%10.61M13.12%9.11M7.65%8.79M-2.89%7.99M17.48%32.91M15.54%8.47M-1.61%8.06M
Research and development costs 35.09%31.86M24.35%27.87M20.99%97.1M21.06%26.03M32.34%25.07M15.48%23.58M15.64%22.41M30.79%80.25M22.66%21.5M19.57%18.94M
Operating profit -32.11%-42.46M-26.67%-38.14M-2.58%-112.87M-27.62%-36.65M47.26%-13.97M-13.05%-32.14M-14.07%-30.11M-54.25%-110.03M-15.97%-28.72M-16.92%-26.5M
Net non-operating interest income expense 200.48%7.55M298.13%5.75M374.58%12.21M227.35%4.38M387.55%3.88M638.82%2.51M1,343.00%1.44M1,778.10%2.57M528.85%1.34M82.76%795K
Non-operating interest income 200.48%7.55M298.13%5.75M374.58%12.21M227.35%4.38M387.55%3.88M638.82%2.51M1,343.00%1.44M1,778.10%2.57M528.85%1.34M82.76%795K
Other net income (expense) -662.50%-45K47.37%-10K-417.14%-181K-466.67%-11K-1,855.56%-158K8K58.70%-19K71.07%-35K142.86%3K169.23%9K
Other non- operating income (expenses) -662.50%-45K47.37%-10K-417.14%-181K-466.67%-11K-1,855.56%-158K--8K58.70%-19K71.07%-35K142.86%3K169.23%9K
Income before tax -18.02%-34.95M-12.97%-32.4M6.19%-100.84M-17.91%-32.28M60.08%-10.26M-5.45%-29.62M-8.90%-28.68M-50.73%-107.49M-9.15%-27.38M-15.52%-25.69M
Income tax
Net income -18.02%-34.95M-12.97%-32.4M6.19%-100.84M-17.91%-32.28M60.08%-10.26M-5.45%-29.62M-8.90%-28.68M-50.73%-107.49M-9.15%-27.38M-15.52%-25.69M
Net income continuous Operations -18.02%-34.95M-12.97%-32.4M6.19%-100.84M-17.91%-32.28M60.08%-10.26M-5.45%-29.62M-8.90%-28.68M-50.73%-107.49M-9.15%-27.38M-15.52%-25.69M
Minority interest income
Net income attributable to the parent company -18.02%-34.95M-12.97%-32.4M6.19%-100.84M-17.91%-32.28M60.08%-10.26M-5.45%-29.62M-8.90%-28.68M-50.73%-107.49M-9.15%-27.38M-15.52%-25.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -18.02%-34.95M-12.97%-32.4M6.19%-100.84M-17.91%-32.28M60.08%-10.26M-5.45%-29.62M-8.90%-28.68M-50.73%-107.49M-9.15%-27.38M-15.52%-25.69M
Basic earnings per share 18.18%-0.6325.00%-0.6622.29%-2.588.33%-0.7769.62%-0.2411.49%-0.77-7.32%-0.88-29.18%-3.321.18%-0.843.66%-0.79
Diluted earnings per share 18.18%-0.6325.00%-0.6622.29%-2.588.33%-0.7769.62%-0.2411.49%-0.77-7.32%-0.88-29.18%-3.321.18%-0.843.66%-0.79
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg